The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CMP-001-007: Open-label, phase 2 study of intratumoral CMP-001 + pembrolizumab in patients with recurrent or metastatic head and neck squamous cell carcinoma.
 
Deborah J.L. Wong
Consulting or Advisory Role - Blueprint Medicines; Bristol-Myers Squibb; Genentech/Roche; Sanofi/Aventis
Research Funding - ARMO BioSciences (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Elevar Therapeutics (Inst); Enzychem Lifesciences (Inst); FSTAR (Inst); Genentech/Roche (Inst); Kura Oncology (Inst); Lilly; Merck Serono (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Regeneron (Inst)
 
Aru Panwar
No Relationships to Disclose
 
Ari Rosenberg
Consulting or Advisory Role - EMD Serono; Nanobiotix
 
Vidhya Karivedu
No Relationships to Disclose
 
Douglas Earl Laux
Speakers' Bureau - Sanofi
Research Funding - Aduro Biotech; Astellas Pharma; Immunicum; Merck; Pfizer; Replimune
 
Dan Paul Zandberg
Consulting or Advisory Role - Blueprint Medicines
Research Funding - Aduro Biotech (Inst); Astellas Pharma (Inst); AstraZeneca Canada (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); GlaxoSmithKline (Inst); ISA Pharmaceuticals (Inst); Merck (Inst)
 
Dmitri Bobilev
Employment - Checkmate Pharmaceuticals
 
Luping Zhao
Employment - Checkmate Pharmaceuticals; Sarepta Therapeutics
Stock and Other Ownership Interests - Checkmate Pharmaceuticals; Codiak Biosciences (I); Sarepta Therapeutics
 
James Wooldridge
Employment - Aeglea Biotherapeutics; Checkmate Pharmaceuticals
Leadership - Aeglea Biotherapeutics; Checkmate Pharmaceuticals
Stock and Other Ownership Interests - Aeglea Biotherapeutics; Checkmate Pharmaceuticals
 
Art M. Krieg
Employment - Checkmate Pharmaceuticals
Leadership - Checkmate Pharmaceuticals
Stock and Other Ownership Interests - Checkmate Pharmaceuticals
Consulting or Advisory Role - Korro Bio; Pfizer; Providence Therapeutics; Recode Therapeutics; Tidal Therapeutics
Patents, Royalties, Other Intellectual Property - patents relating to oligonucleotide technologies and assigned to Checkmate Pharma
 
Ezra E.W. Cohen
Consulting or Advisory Role - Bayer; BioNTech; Eisai; Gilead Sciences; Merck; MSD; Regeneron